KIMBERLY CLARK Business Summary

Kimberly-Clark Corporation (KMB) generates revenue primarily through the global manufacture and marketing of essential consumer products, operating across three core segments: Personal Care, Consumer Tissue, and K-C Professional. As of early 2026, the company is executing a radical "Pure-Play Personal Care" transformation, highlighted by a $3.4 billion joint venture with Suzano to deconsolidate its International Family Care business and the pending multi-billion dollar acquisition of Kenvue to bolster its branded health and hygiene portfolio. The company’s revenue model is transaction-based, leveraging iconic brands like Huggies, Kleenex, and Kotex to maintain a dominant presence in retail and B2B channels. Kimberly-Clark competes directly with Procter & Gamble, Unilever, and Essity, positioning itself as a high-margin, innovation-led leader that prioritizes volume-plus-mix growth and productivity-driven margin expansion over commodity-heavy paper production. Originally founded in 1872 by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Franklyn C. Shattuck, the company is currently led by Chairman and CEO Michael D. Hsu, a veteran of Kraft Foods and H.J. Heinz who has spearheaded the firm's recent structural metamorphosis. The executive team includes President and COO Russ Torres, who oversees day-to-day operations and global supply chains, and CFO Nelson Urdaneta, formerly of Mondelēz International. Technology and innovation efforts are directed by Chief Digital and Technology Officer Zackery Hicks (slated to depart in late March 2026) and Chief R&D Officer Craig Slavtcheff, a former Campbell Soup Company executive. The Board of Directors features notable figures such as Dr. Mae C. Jemison and Joseph Romanelli, President of Human Health International at Merck, reflecting a strategic emphasis on scientific innovation and global market scaling.